The most frequent issues reported from the phase 3 studies are nausea (19%), fatigue (6%), skin darkening (4%), dizziness (4%), and the development of moles (4%)
International Journal of Yoga , 14 (1), 26
Guidance for Industry: Clinical Trial Imaging Endpoint Process Standards
Gastroenterology 141:150156 Gier B, Matveyenko AV, Kirakossian D, Dawson D, Dry SM, Butler PC (2012) Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model
Insurance coverage for tirzepatide is limited and often requires extensive documentation, prior authorizations, and step therapy failures before approval
The assumption is simple: if some works, more must work better